These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
945 related items for PubMed ID: 11900248
1. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Gupta RA, Dubois RN. Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248 [Abstract] [Full Text] [Related]
2. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma]. Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ. Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2207-12. PubMed ID: 14640057 [Abstract] [Full Text] [Related]
3. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms. Nasir A, Fernandez PM, Chughtai OR, Kaiser HE. In Vivo; 2002 Nov 08; 16(6):501-9. PubMed ID: 12494894 [Abstract] [Full Text] [Related]
4. Use of NSAIDs for the chemoprevention of colorectal cancer. Herendeen JM, Lindley C. Ann Pharmacother; 2003 Nov 08; 37(11):1664-74. PubMed ID: 14565811 [Abstract] [Full Text] [Related]
5. [Colorectal cancer and inhibition of cyclooxygenase-2]. Geissler M, Mohr L, Blum HE. Dtsch Med Wochenschr; 2002 Jun 07; 127(23):1256-8. PubMed ID: 12053285 [No Abstract] [Full Text] [Related]
6. COX-2 inhibition as a tool to treat and prevent colorectal cancer. Tuynman JB, Peppelenbosch MP, Richel DJ. Crit Rev Oncol Hematol; 2004 Nov 07; 52(2):81-101. PubMed ID: 15501074 [Abstract] [Full Text] [Related]
7. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II. Moyad MA. Semin Urol Oncol; 2001 Nov 07; 19(4):306-16. PubMed ID: 11769882 [Abstract] [Full Text] [Related]
10. NSAIDs to prevent colorectal cancer: a question of sensitivity. Elder DJ, Paraskeva C. Gastroenterology; 1997 Dec 07; 113(6):1999-2003. PubMed ID: 9394741 [No Abstract] [Full Text] [Related]
11. COX-2: a molecular target for colorectal cancer prevention. Brown JR, DuBois RN. J Clin Oncol; 2005 Apr 20; 23(12):2840-55. PubMed ID: 15837998 [Abstract] [Full Text] [Related]
12. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Dannenberg AJ, Zakim D. Semin Oncol; 1999 Oct 20; 26(5):499-504. PubMed ID: 10528897 [Abstract] [Full Text] [Related]
13. COX-2-specific inhibition: implications for clinical practice. Pascucci RA. J Am Osteopath Assoc; 1999 Nov 20; 99(11 Suppl):S18-22. PubMed ID: 10643177 [Abstract] [Full Text] [Related]
14. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective]. Kleibeuker JH, de Vries EG. Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2203-7. PubMed ID: 14640056 [Abstract] [Full Text] [Related]
15. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review. Pruthi RS, Derksen E, Gaston K. J Urol; 2003 Jun 08; 169(6):2352-9. PubMed ID: 12771797 [Abstract] [Full Text] [Related]
16. Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side. Samoha S, Arber N. Oncology; 2005 Jun 08; 69 Suppl 1():33-7. PubMed ID: 16210875 [Abstract] [Full Text] [Related]
17. [Cyclooxygenase-2 (COX-2) in digestive cancer. Therapeutic implications]. Bessa X, Piñol V, Elizalde JI, Castells A. Gastroenterol Hepatol; 2000 Dec 08; 23(10):483-90. PubMed ID: 11149225 [No Abstract] [Full Text] [Related]